Arlington Partners’s AstraZeneca AZN Stock Holding History

Arlington Partners’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-211	Closed	-$28.4K	–	77
2023 Q4	$28.4K	Buy	+211	New	+$27.4K	0.01%	166
2023 Q3	–	Sell	-428	Closed	-$61.3K	–	368
2023 Q2	$61.3K	Buy	428 +175	+69%	+$25.7K	0.01%	287
2023 Q1	$35.1K	Buy	253 +42	+20%	+$5.65K	0.01%	291
2022 Q4	$28.6K	Hold	211	–	–	﹤0.01%	271
2022 Q3	$23K	Hold	211	–	–	0.01%	249
2022 Q2	$28K	Hold	211	–	–	0.01%	290
2022 Q1	$28K	Hold	211	–	–	0.01%	294
2021 Q4	$25K	Buy	+211	New	+$24.8K	0.01%	347

Other funds holding AZN

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sanders Capital

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return